Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PROMACTA for Chronic hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where PROMACTA was used for Chronic hepatitis c.

Most Reported Side Effects for PROMACTA

Side Effect Reports % Deaths Hosp.
Platelet count decreased 34 11.5% 0 9
Death 29 9.8% 29 5
Drug ineffective 26 8.8% 1 4
Investigation 17 5.7% 1 17
Nausea 16 5.4% 0 0
Diarrhoea 13 4.4% 0 2
Headache 12 4.0% 0 1
Platelet count increased 12 4.0% 0 3
Treatment noncompliance 12 4.0% 0 2
Fatigue 11 3.7% 0 2
Abdominal pain upper 9 3.0% 1 1
Pain in extremity 8 2.7% 0 1
Rash 8 2.7% 0 0
Asthenia 7 2.4% 0 1
Dizziness 7 2.4% 0 1

Other Indications for PROMACTA

Immune thrombocytopenic purpura (102) Product used for unknown indication (88) Thrombocytopenia (29) Platelet count decreased (15) Hepatitis c (10)

Other Drugs Used for Chronic hepatitis c

RIBAVIRIN (15,707) PEGINTERFERON ALFA-2A (7,898) LEDIPASVIR\SOFOSBUVIR (6,621) SOFOSBUVIR\VELPATASVIR (6,405) SOFOSBUVIR (6,008) TELAPREVIR (3,103) GLECAPREVIR\PIBRENTASVIR (3,072) SIMEPREVIR (2,735) DACLATASVIR (2,063) PEGINTERFERON ALFA-2B (1,927)

Related Pages

PROMACTA Full Profile All Chronic hepatitis c Drugs PROMACTA Demographics PROMACTA Timeline